Cite

HARVARD Citation

    Van Cutsem, E. et al. (n.d.). LBA-05Results from the large, open-label phase 3b CONSIGN study of regorafenib in patients with previously treated metastatic colorectal cancer. Annals of oncology. p. iv118. [Online]. 
  
Back to record